Trials / Completed
CompletedNCT06629441
Effectiveness and Safety of Probiotics in Relieving Anxiety and Depression
Effectiveness and Safety of Probiotics, BC99 in Relieving Anxiety and Depression in Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Wecare Probiotics Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the effectiveness and safety of probiotics in relieving anxiety and depression in adults, in comparison with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic group | taking 10 billion CFU probiotic one sachet one time, lasting 56 days. |
| DIETARY_SUPPLEMENT | Placebo group | taking maltodaxtrin one sachet one time, lasting 56 days. |
Timeline
- Start date
- 2024-06-20
- Primary completion
- 2024-12-15
- Completion
- 2025-01-14
- First posted
- 2024-10-08
- Last updated
- 2025-08-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06629441. Inclusion in this directory is not an endorsement.